Medidata to Showcase New Study Experience Capabilities for Sites and Sponsors at SCOPE 2025
Company experts to demonstrate how the Study Experience portfolio reduces study design and execution timelines
New York - Feb. 3, 2025 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, will unveil advancements to its Study Experience solutions at the annual Summit for Clinical Ops Executives (SCOPE), in Orlando, Fla., from Feb. 3-6, 2025. As a signature sponsor, Medidata will highlight how its AI-powered, data-driven insights optimize study design and implementation by enabling simulation of trial design and process simplification.
“At SCOPE 2025, we will demonstrate how integrating AI across the clinical trial journey is empowering customers to move from the reactionary nature of trial management into a more generative and predictive approach,” said Dan Braga, senior vice president, study experience, Medidata. “Overall, we are dedicated to reshaping how organizations design, plan, and manage trials end-to-end with the greatest impact.”
In addition, the Experience will improve research design and financial management processes, shorten study build timelines, and enhance data governance. These new innovations will also support efforts to increase patient diversity and simplify trial oversight, benefiting both sites and sponsors.
Medidata’s presence will also include an exhibit booth (#903) and a customer meeting room. Additionally for the conference, the company will be partnering with the Oliver Patch Project to create custom designed patches. Event attendees will be able to send these unique patches alongside customized messages to pediatric clinical trial patients as part of the Oliver Patch Project Mission.
At SCOPE 2024, the company won a couple awards, including the Sites Innovation Award for Medidata Rave Companion.
Medidata’s schedule of presentations at the summit is listed below. For a complete SCOPE agenda, please visit here.
Tuesday, Feb. 4, 2025
- 11:55 AM: Help Is Here: Interpreting the New ICH E6 R3 Data Governance Requirements
- Arlene Lee, Director, Product Management, Data Quality and Risk Management Solutions, Medidata
- Tashan K. Mistree, MS, Senior Director Business Operations, GSK
- 12:35 PM: Streamlining Clinical Trials with AI-powered insights: An End-to-End Approach to Design, Planning, and Execution
- Rob Buka, Sr. Director, Product Management, Medidata
- Kelly Hoang, Associate Director, Data Scientist, Gilead
- 3:55 PM: From Insight to Excellence: Leveraging Deep Domain Knowledge, Operational Leadership, and Clinical Supplies Expertise for Strategic Trial Success
- Stephanie Russell, Sr. Director RTSM Solution Services, Medidata
- 4:25 PM: Optimizing Usability is Optimizing Data Quality - Elevating CNS Endpoint Data through Patient and Site-Centric Solutions
- Holly Robertson, PhD, Head of Advisory Services, Medidata
- Karin Wallace, Associate Vice President, Client Solutions & Strategic Accounts, Cogstate
- 4:55 PM: Advancements and Challenges in Clinical Trial Data Quality Control: A Roadmap for Audit Trail Analysis
- Olgica Klindworth, VP, Data Quality and Risk Management Solutions, Medidata
- Jennifer Krohn, MS, Associate Director, RBQM, Clinical Operations, Gilead Sciences, Inc.
- Simon Walsh, Senior Director, Data Management and Central Monitoring, J&J Innovative Medicines
- Kevin Stephenson MS, Executive Director Data Management, Karyopharm Therapeutics
Wednesday, Feb. 5, 2025
- 8:55 AM: Investigator-Initiated Studies: Budgeting Practices for Time and Cost Savings
- Meghan Harrington, VP Clinical Trial Financial Management, Medidata
- Michael Salvatore, Director, Process & Systems, Merck
- 9:55 AM: Accelerating Study Build with Generative AI
- Wayne Walker, SVP, Rave Platform Technology, Medidata
- 12:25 PM: 360° Monitoring: A New Approach to Dynamic Clinical Oversight using Centralized Insights
- Olgica Klindworth, VP, Data Quality and Risk Management Solutions, Medidata
- Lauren Price, Director, CTMS Product Management, Medidata
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. With Dassault Systèmes’ 3DEXPERIENCE platform, 350,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact. For more information, visit: www.3ds.com